BIOMOTION PHARMA ApS — Credit Rating and Financial Key Figures
CVR number: 12928203
Stockholmsgade 37, 2100 København Ø
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 16.00 | ||||
| External services | -1.25 | -1.25 | -9.80 | -1.43 | -5.31 |
| Gross profit | -1.25 | -1.25 | 6.20 | -1.43 | -5.31 |
| EBIT | -1.25 | -1.25 | 6.20 | -1.43 | -5.31 |
| Other financial income | 5.00 | ||||
| Other financial expenses | -1.15 | ||||
| Pre-tax profit | -1.25 | 3.75 | 6.20 | -1.43 | -6.46 |
| Net earnings | -1.25 | 3.75 | 6.20 | -1.43 | -6.46 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current other receivables | 2.50 | 6.25 | 12.45 | 11.02 | 7.80 |
| Short term receivables total | 2.50 | 6.25 | 12.45 | 11.02 | 7.80 |
| Balance sheet total (assets) | 2.50 | 6.25 | 12.45 | 11.02 | 7.80 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 |
| Retained earnings | - 122.50 | - 123.75 | - 120.00 | - 113.80 | - 115.23 |
| Profit of the financial year | -1.25 | 3.75 | 6.20 | -1.43 | -6.46 |
| Shareholders equity total | 1.25 | 5.00 | 11.20 | 9.77 | 3.31 |
| Non-current liabilities total | |||||
| Current trade creditors | 1.25 | 1.25 | 1.25 | 1.25 | 3.34 |
| Other non-interest bearing current liabilities | 1.15 | ||||
| Current liabilities total | 1.25 | 1.25 | 1.25 | 1.25 | 4.49 |
| Balance sheet total (liabilities) | 2.50 | 6.25 | 12.45 | 11.02 | 7.80 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.